Diagnosis of inherited bleeding disorders in the genomic era

Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), pla...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 179; no. 3; pp. 363 - 376
Main Authors Sivapalaratnam, Suthesh, Collins, Janine, Gomez, Keith
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.11.2017
Subjects
Online AccessGet full text
ISSN0007-1048
1365-2141
1365-2141
DOI10.1111/bjh.14796

Cover

Abstract Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.
AbstractList Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.
Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.
Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.
Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha‐2‐antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.
Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of alpha-2-antiplasmin deficiency. Those with an identifiable abnormality can be divided into disorders of coagulation factors (87%), platelet count and function (8%) and the fibrinolytic system (3%). Of the patients registered in the UK with a bleeding disorder, the remaining 2% are unclassifiable. In addition to bleeding symptoms, patients with an inherited bleeding disorder can manifest other abnormalities, making an accurate and complete diagnosis that reflects the underlying molecular pathology important. Although some inherited bleeding disorders can still be easily diagnosed through a combination of careful clinical assessment and laboratory assays of varying degrees of complexity, there are many where conventional approaches are inadequate. Improvements in phenotyping assays have enhanced our diagnostic armoury but genotyping now offers the most accurate and complete diagnosis for some of these conditions. The advent of next generation sequencing technology has meant that many genes can now be analysed routinely in clinical practice. Here, we discuss the different diagnostic tools currently available for inherited bleeding disorders and suggest that genotyping should be incorporated at an early stage in the diagnostic pathway.
Author Gomez, Keith
Sivapalaratnam, Suthesh
Collins, Janine
Author_xml – sequence: 1
  givenname: Suthesh
  surname: Sivapalaratnam
  fullname: Sivapalaratnam, Suthesh
  organization: The Royal London Hospital
– sequence: 2
  givenname: Janine
  surname: Collins
  fullname: Collins, Janine
  organization: The Royal London Hospital
– sequence: 3
  givenname: Keith
  surname: Gomez
  fullname: Gomez, Keith
  email: k.gomez@ucl.ac.uk
  organization: Royal Free London NHS Foundation Trust
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28612396$$D View this record in MEDLINE/PubMed
BookMark eNp10EtPGzEUBWCrooKEsugfqEbqBhZDrh8znpG64VlaIXXTri3bc504mtjUngjx7zFN2CDqjRf-zpF15uQgxICEfKZwTstZmPXqnArZtx_IjPK2qRkV9IDMAEDWFER3ROY5rwEoh4YekiPWtZTxvp2Rb9deL0PMPlfRVT6sMPkJh8qMiIMPy2rwOaYBUy6P1bTCaokhbrytMOlP5KPTY8aT_X1M_tze_L66q-9_ff9xdXFfW97wthbAgFl0HWtBciE5Mx3rmDatcEPjKDXaMdDS0l44axyYhhoU0jLWImjGj8nprvchxb9bzJPa-GxxHHXAuM2K9tBLwRroCv36hq7jNoXyu6Ia0UMnuSzqy15tzQYH9ZD8Rqcn9bpLAYsdsCnmnNAp6yc9-RimpP2oKKiX5VVZXv1bviTO3iReS9-z-_ZHP-LT_6G6_Hm3SzwDpDiPkg
CitedBy_id crossref_primary_10_1097_MBC_0000000000000992
crossref_primary_10_1182_hematology_2021000236
crossref_primary_10_1097_MBC_0000000000000990
crossref_primary_10_1159_000507689
crossref_primary_10_1111_bjh_15886
crossref_primary_10_1111_hae_13948
crossref_primary_10_1080_09537104_2020_1869714
crossref_primary_10_1093_labmed_lmac005
crossref_primary_10_1097_MOH_0000000000000525
crossref_primary_10_1002_jha2_664
crossref_primary_10_1515_cclm_2017_0972
crossref_primary_10_1111_scd_12713
crossref_primary_10_3390_ijms22094521
crossref_primary_10_1055_s_0044_1787661
crossref_primary_10_1097_ALN_0000000000004520
crossref_primary_10_1111_hae_13637
crossref_primary_10_1177_1076029618820164
crossref_primary_10_1111_jth_14945
crossref_primary_10_1111_jth_15479
crossref_primary_10_1016_j_paed_2017_09_001
crossref_primary_10_1111_hae_14042
crossref_primary_10_3390_ijms23147647
crossref_primary_10_1016_j_transci_2019_06_013
crossref_primary_10_1080_17474086_2019_1670638
crossref_primary_10_1002_mgg3_1075
crossref_primary_10_7759_cureus_16964
crossref_primary_10_1111_bjh_15833
crossref_primary_10_3390_biom14060714
crossref_primary_10_1002_rth2_12637
crossref_primary_10_1002_humu_24114
crossref_primary_10_1055_a_1726_4793
crossref_primary_10_1016_j_jtha_2023_11_011
crossref_primary_10_1111_hae_14195
crossref_primary_10_1080_09537104_2019_1663803
crossref_primary_10_1111_bjh_16165
crossref_primary_10_14302_issn_2372_6601_jhor_24_5108
crossref_primary_10_1111_bjh_17690
crossref_primary_10_1177_1076029618790696
crossref_primary_10_1111_hae_14438
crossref_primary_10_1186_s12859_019_2919_x
crossref_primary_10_1111_hae_13922
crossref_primary_10_1055_a_2099_3266
crossref_primary_10_1016_j_ejmg_2021_104228
crossref_primary_10_1007_s00590_024_04073_8
crossref_primary_10_1080_17474086_2023_2211257
crossref_primary_10_3390_ijms22052758
crossref_primary_10_3390_jcm10020347
Cites_doi 10.1126/scitranslmed.aad7666
10.1111/hae.13089
10.1186/s12881-014-0135-0
10.1002/ajh.23619
10.1182/blood-2015-12-688267
10.1182/blood-2015-09-671636
10.1111/jth.12276
10.1111/hae.12908
10.1111/jth.12332
10.1038/nature08494
10.1182/blood.V77.3.528.528
10.1182/blood-2014-08-532820
10.1111/j.1365-2141.2011.08793.x
10.1111/bjh.13058
10.1182/blood-2016-03-378588
10.1182/blood-2015-10-675629
10.1111/jth.12792
10.1182/blood-2008-08-173278
10.1182/blood-2008-06-162958
10.1016/j.cell.2016.10.042
10.1111/jth.13269
10.1172/JCI80347
10.5482/HAMO-15-05-0017
10.1093/nar/gkv1222
10.1097/MOH.0b013e3283497e3e
10.1111/j.1365-2516.2012.02759.x
10.1172/JCI86154
10.1111/j.1365-2141.2005.05599.x
10.1182/blood-2015-11-683102
10.1182/blood-2009-05-219808
10.1080/09537100802082256
10.1055/s-0029-1145254
10.1046/j.1365-2141.2001.02845.x
10.1055/s-0037-1613258
10.1111/j.1538-7836.2010.03975.x
10.1111/bjh.14471
10.1111/jth.12836
10.1038/ejhg.2015.226
10.1111/jth.12966
10.1038/ng.883
10.1097/MBC.0000000000000496
10.1111/j.1538-7836.2011.04569.x
ContentType Journal Article
Copyright 2017 John Wiley & Sons Ltd
2017 John Wiley & Sons Ltd.
Copyright © 2017 John Wiley & Sons Ltd
Copyright_xml – notice: 2017 John Wiley & Sons Ltd
– notice: 2017 John Wiley & Sons Ltd.
– notice: Copyright © 2017 John Wiley & Sons Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
DOI 10.1111/bjh.14796
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2141
EndPage 376
ExternalDocumentID 28612396
10_1111_bjh_14796
BJH14796
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: British Heart Foundation
– fundername: Medical Research Council
  grantid: MR/P02002X/1
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1KJ
1OB
1OC
23N
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYEP
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EGARE
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IH2
IHE
IX1
J0M
J5H
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
V9Y
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
ID FETCH-LOGICAL-c3536-40202cef8260734732b8282ab64fd5f11baf20a7c194fcbf0b51be47c226e0a23
IEDL.DBID DR2
ISSN 0007-1048
1365-2141
IngestDate Thu Jul 10 17:47:14 EDT 2025
Fri Jul 25 10:07:30 EDT 2025
Mon Jul 21 05:50:36 EDT 2025
Thu Apr 24 23:09:36 EDT 2025
Tue Jul 01 02:05:59 EDT 2025
Wed Jan 22 17:05:19 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords bleeding disorders
diagnostic haematology
genetics
platelet disorders
Language English
License 2017 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3536-40202cef8260734732b8282ab64fd5f11baf20a7c194fcbf0b51be47c226e0a23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
PMID 28612396
PQID 1954908737
PQPubID 36395
PageCount 14
ParticipantIDs proquest_miscellaneous_1909742508
proquest_journals_1954908737
pubmed_primary_28612396
crossref_citationtrail_10_1111_bjh_14796
crossref_primary_10_1111_bjh_14796
wiley_primary_10_1111_bjh_14796_BJH14796
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2017
2017-11-00
20171101
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle British journal of haematology
PublicationTitleAlternate Br J Haematol
PublicationYear 2017
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2015; 13
2005; 130
1991; 77
2015; 125
2008; 19
2016; 167
2008; 34
2009; 113
2016; 128
2012; 18
2016; 127
2017; 176
2016a; 25
2011; 18
2016; 36
2012; 10
2011; 8
2009; 114
2014; 89
2016; 14
2011; 155
2013; 11
2016b; 22
2010; 115
2002; 88
2014; 15
2011; 43
2009; 461
2016; 27
2012; 22
2016; 8
2001; 114
2016; 24
2017; 127
2014; 167
2016; 22
2016; 44
e_1_2_13_25_1
e_1_2_13_24_1
e_1_2_13_27_1
e_1_2_13_26_1
e_1_2_13_21_1
e_1_2_13_44_1
e_1_2_13_20_1
e_1_2_13_45_1
e_1_2_13_23_1
Nurden A. (e_1_2_13_31_1) 2012; 22
e_1_2_13_42_1
e_1_2_13_22_1
e_1_2_13_43_1
Bastida J.M. (e_1_2_13_7_1) 2016; 25
e_1_2_13_9_1
e_1_2_13_40_1
e_1_2_13_8_1
e_1_2_13_41_1
e_1_2_13_6_1
e_1_2_13_17_1
e_1_2_13_18_1
e_1_2_13_39_1
e_1_2_13_19_1
e_1_2_13_13_1
e_1_2_13_36_1
e_1_2_13_14_1
e_1_2_13_35_1
e_1_2_13_15_1
e_1_2_13_38_1
e_1_2_13_16_1
e_1_2_13_37_1
e_1_2_13_32_1
e_1_2_13_10_1
e_1_2_13_11_1
e_1_2_13_34_1
e_1_2_13_12_1
e_1_2_13_33_1
e_1_2_13_30_1
e_1_2_13_5_1
e_1_2_13_4_1
e_1_2_13_3_1
e_1_2_13_2_1
e_1_2_13_29_1
e_1_2_13_28_1
References_xml – volume: 167
  start-page: 304
  year: 2014
  end-page: 326
  article-title: Guideline for the diagnosis and management of the rare coagulation disorders
  publication-title: British Journal of Haematology
– volume: 11
  start-page: 1663
  year: 2013
  end-page: 1668
  article-title: Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 8
  start-page: 328ra30
  year: 2016
  article-title: A dominant gain‐of‐function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
  publication-title: Science Translational Medicine
– volume: 128
  start-page: 1282
  year: 2016
  end-page: 1289
  article-title: Novel mutations in RASGRP2, which encodes CalDAG‐GEFI, abrogate Rap1 activation, causing platelet dysfunction
  publication-title: Blood
– volume: 43
  start-page: 732
  year: 2011
  end-page: 734
  article-title: NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α‐granules
  publication-title: Nature Genetics
– volume: 10
  start-page: 306
  year: 2012
  end-page: 309
  article-title: Rapid genetic diagnosis of heritable platelet function disorders with next‐generation sequencing: proof‐of‐principle with Hermansky‐Pudlak syndrome
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 19
  start-page: 440
  year: 2008
  end-page: 446
  article-title: Testing agonist‐induced platelet aggregation by the Impact‐R [Cone and plate(let) analyzer (CPA)]
  publication-title: Platelets
– volume: 125
  start-page: 3600
  year: 2015
  end-page: 3605
  article-title: SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects
  publication-title: The Journal of Clinical Investigation
– volume: 114
  start-page: 1091
  year: 2009
  end-page: 1099
  article-title: A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3
  publication-title: Blood
– volume: 115
  start-page: 1267
  year: 2010
  end-page: 1276
  article-title: The mouse mutation ‘thrombocytopenia and cardiomyopathy’ (trac) disrupts Abcg5: a spontaneous single gene model for human hereditary phytosterolemia/sitosterolemia
  publication-title: Blood
– volume: 125
  start-page: 2052
  year: 2015
  end-page: 2062
  article-title: Rare bleeding disorders : diagnosis and treatment
  publication-title: Blood
– volume: 77
  start-page: 528
  year: 1991
  end-page: 532
  article-title: A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1
  publication-title: Blood
– volume: 15
  start-page: 135
  year: 2014
  article-title: Recessive thrombocytopenia likely due to a homozygous pathogenic variant in the FYB gene: case report
  publication-title: BMC Medical Genetics
– volume: 8
  start-page: 2063
  year: 2011
  end-page: 2065
  article-title: Bleeding assesment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 127
  start-page: 2814
  year: 2016
  end-page: 2823
  article-title: Inherited platelet disorders: toward DNA‐based diagnosis
  publication-title: Blood
– volume: 89
  start-page: 320
  year: 2014
  end-page: 324
  article-title: Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia
  publication-title: American Journal of Hematology
– volume: 27
  start-page: 589
  year: 2016
  end-page: 593
  article-title: The utility of International Society on Thrombosis and Haemostasis‐Bleeding Assessment Tool and other bleeding questionnaires in assessing the bleeding phenotype in two platelet function defects
  publication-title: Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis
– volume: 13
  start-page: 314
  year: 2015
  end-page: 322
  article-title: Diagnosis of inherited platelet function disorders : guidance from the SSC of the ISTH
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 22
  start-page: 30
  year: 2012
  end-page: 41
  article-title: Inherited platelet disorders
  publication-title: Haemophilia
– volume: 127
  start-page: 814
  year: 2017
  end-page: 829
  article-title: Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia
  publication-title: The Journal of Clinical Investigation
– volume: 113
  start-page: e1
  year: 2009
  end-page: e9
  article-title: A HaemAtlas: characterizing gene expression in differentiated human blood cells
  publication-title: Blood
– volume: 36
  start-page: S25
  year: 2016
  end-page: S28
  article-title: Mutational spectrum and deep intronic variants in the factor VIII gene of haemophilia A patients. Identification by next generation sequencing
  publication-title: Hamostaseologie
– volume: 18
  start-page: 366
  year: 2011
  end-page: 372
  article-title: Novel aspects of factor XIII deficiency
  publication-title: Current Opinion in Hematology
– volume: 127
  start-page: 997
  year: 2016
  end-page: 1006
  article-title: Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky‐Pudlak syndrome
  publication-title: Blood
– volume: 24
  start-page: 2
  year: 2016
  end-page: 5
  article-title: Guidelines for diagnostic next‐generation sequencing
  publication-title: European Journal of Human Genetics
– volume: 114
  start-page: 4
  year: 2001
  end-page: 10
  article-title: Congential alfa‐2‐plasmin inhibitor deficienceis: A review
  publication-title: British Journal of Haematology
– volume: 127
  start-page: 2791
  year: 2016
  end-page: 2804
  article-title: A comprehensive high‐throughput sequencing test for the diagnosis of inherited bleeding, thrombotic and platelet disorders
  publication-title: Blood
– volume: 22
  start-page: 590
  year: 2016b
  end-page: 597
  article-title: Design and application of a 23‐gene panel by next‐generation sequencing for inherited coagulation bleeding disorders
  publication-title: Haemophilia
– volume: 13
  start-page: 1285
  year: 2015
  end-page: 1292
  article-title: Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small‐platelet thrombocytopenia
  publication-title: Journal of Thrombosis and Haemostasis : JTH
– volume: 25
  start-page: 1
  year: 2016a
  end-page: 4
  article-title: Wiskott‐Aldrich syndrome in a child presenting with macrothrombocytopenia
  publication-title: Platelets
– volume: 14
  start-page: 839
  year: 2016
  end-page: 849
  article-title: Super‐resolution microscopy as a potential approach to diagnosis of platelet granule disorders
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 11
  start-page: 1329
  year: 2013
  end-page: 1340
  article-title: An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 167
  start-page: 1415
  year: 2016
  end-page: 1429
  article-title: The allelic landscape of human blood cell trait variation and links to common complex disease resource the allelic landscape of human blood cell trait variation and links to common complex disease
  publication-title: Cell
– volume: 22
  start-page: 912
  year: 2016
  end-page: 918
  article-title: Evaluation of the utility of the ISTH‐BAT in haemophilia carriers: a multinational study
  publication-title: Haemophilia
– volume: 44
  start-page: D862
  year: 2016
  end-page: D868
  article-title: ClinVar: public archive of interpretations of clinically relevant variants
  publication-title: Nucleic Acids Research
– volume: 176
  start-page: 705
  year: 2017
  end-page: 720
  article-title: Dawning of the age of genomics for platelet granule disorders: improving insight, diagnosis and management
  publication-title: British Journal of Haematology
– volume: 461
  start-page: 747
  year: 2009
  end-page: 753
  article-title: Finding the missing heritability of complex diseases
  publication-title: Nature
– volume: 130
  start-page: 297
  year: 2005
  end-page: 309
  article-title: Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia
  publication-title: British Journal of Haematology
– volume: 34
  start-page: 709
  year: 2008
  end-page: 733
  article-title: Clinical utility of the PFA‐100
  publication-title: Seminars in Thrombosis and Hemostasis
– volume: 13
  start-page: 643
  year: 2015
  end-page: 650
  article-title: Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
  publication-title: Journal of Thrombosis and Haemostasis
– volume: 155
  start-page: 30
  year: 2011
  end-page: 44
  article-title: Guidelines for the laboratory investigation of heritable disorders of platelet function
  publication-title: British Journal of Haematology
– volume: 127
  start-page: 2903
  year: 2016
  end-page: 2914
  article-title: A gain‐of‐function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss
  publication-title: Blood
– volume: 18
  start-page: 630
  year: 2012
  end-page: 638
  article-title: Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders
  publication-title: Haemophilia
– volume: 88
  start-page: 576
  year: 2002
  end-page: 582
  article-title: The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding
  publication-title: Thrombosis and Haemostasis
– volume: 22
  start-page: 30
  year: 2012
  ident: e_1_2_13_31_1
  article-title: Inherited platelet disorders
  publication-title: Haemophilia
– ident: e_1_2_13_41_1
  doi: 10.1126/scitranslmed.aad7666
– ident: e_1_2_13_18_1
  doi: 10.1111/hae.13089
– ident: e_1_2_13_16_1
  doi: 10.1186/s12881-014-0135-0
– ident: e_1_2_13_43_1
  doi: 10.1002/ajh.23619
– ident: e_1_2_13_38_1
  doi: 10.1182/blood-2015-12-688267
– ident: e_1_2_13_3_1
  doi: 10.1182/blood-2015-09-671636
– ident: e_1_2_13_34_1
  doi: 10.1111/jth.12276
– ident: e_1_2_13_8_1
  doi: 10.1111/hae.12908
– ident: e_1_2_13_25_1
  doi: 10.1111/jth.12332
– ident: e_1_2_13_27_1
  doi: 10.1038/nature08494
– ident: e_1_2_13_10_1
  doi: 10.1182/blood.V77.3.528.528
– ident: e_1_2_13_32_1
  doi: 10.1182/blood-2014-08-532820
– volume: 25
  start-page: 1
  year: 2016
  ident: e_1_2_13_7_1
  article-title: Wiskott‐Aldrich syndrome in a child presenting with macrothrombocytopenia
  publication-title: Platelets
– ident: e_1_2_13_17_1
  doi: 10.1111/j.1365-2141.2011.08793.x
– ident: e_1_2_13_29_1
  doi: 10.1111/bjh.13058
– ident: e_1_2_13_22_1
  doi: 10.1182/blood-2016-03-378588
– ident: e_1_2_13_39_1
  doi: 10.1182/blood-2015-10-675629
– ident: e_1_2_13_14_1
  doi: 10.1111/jth.12792
– ident: e_1_2_13_40_1
  doi: 10.1182/blood-2008-08-173278
– ident: e_1_2_13_44_1
  doi: 10.1182/blood-2008-06-162958
– ident: e_1_2_13_4_1
  doi: 10.1016/j.cell.2016.10.042
– ident: e_1_2_13_45_1
  doi: 10.1111/jth.13269
– ident: e_1_2_13_13_1
  doi: 10.1172/JCI80347
– ident: e_1_2_13_5_1
  doi: 10.5482/HAMO-15-05-0017
– ident: e_1_2_13_21_1
  doi: 10.1093/nar/gkv1222
– ident: e_1_2_13_30_1
  doi: 10.1097/MOH.0b013e3283497e3e
– ident: e_1_2_13_42_1
  doi: 10.1111/j.1365-2516.2012.02759.x
– ident: e_1_2_13_33_1
  doi: 10.1172/JCI86154
– ident: e_1_2_13_35_1
  doi: 10.1111/j.1365-2141.2005.05599.x
– ident: e_1_2_13_26_1
  doi: 10.1182/blood-2015-11-683102
– ident: e_1_2_13_9_1
  doi: 10.1182/blood-2009-05-219808
– ident: e_1_2_13_37_1
  doi: 10.1080/09537100802082256
– ident: e_1_2_13_11_1
  doi: 10.1055/s-0029-1145254
– ident: e_1_2_13_12_1
  doi: 10.1046/j.1365-2141.2001.02845.x
– ident: e_1_2_13_2_1
  doi: 10.1055/s-0037-1613258
– ident: e_1_2_13_36_1
  doi: 10.1111/j.1538-7836.2010.03975.x
– ident: e_1_2_13_6_1
  doi: 10.1111/bjh.14471
– ident: e_1_2_13_23_1
  doi: 10.1111/jth.12836
– ident: e_1_2_13_28_1
  doi: 10.1038/ejhg.2015.226
– ident: e_1_2_13_24_1
  doi: 10.1111/jth.12966
– ident: e_1_2_13_15_1
  doi: 10.1038/ng.883
– ident: e_1_2_13_20_1
  doi: 10.1097/MBC.0000000000000496
– ident: e_1_2_13_19_1
  doi: 10.1111/j.1538-7836.2011.04569.x
SSID ssj0013051
Score 2.4521484
SecondaryResourceType review_article
Snippet Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases...
Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases worldwide of...
Summary Inherited bleeding disorders affect between 1 in 1000 individuals for the most common disorder, von Willebrand Disease, to only 8 reported cases...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 363
SubjectTerms Abnormalities, Multiple - diagnosis
Abnormalities, Multiple - genetics
Bleeding
bleeding disorders
Blood Coagulation Disorders, Inherited - diagnosis
Blood Coagulation Disorders, Inherited - genetics
Blood Platelet Disorders - diagnosis
Blood Platelet Disorders - genetics
Diagnosis
Diagnosis, Differential
diagnostic haematology
Fibrin
genetics
Genomics - methods
Genotype
Genotyping
Hematology
Hemophilia
High-Throughput Nucleotide Sequencing - methods
Humans
Incidental Findings
Phenotyping
Physical Examination - methods
platelet disorders
Platelet Function Tests - methods
von Willebrand Diseases - diagnosis
von Willebrand Diseases - genetics
Title Diagnosis of inherited bleeding disorders in the genomic era
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbjh.14796
https://www.ncbi.nlm.nih.gov/pubmed/28612396
https://www.proquest.com/docview/1954908737
https://www.proquest.com/docview/1909742508
Volume 179
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JTyQhFH4xHoyXcVxGe1yCZg5eylBALWS8uKZjogejiQeTClAQ26Xa2N0Xf_08qEUdNTHeKuFRVAEffA8eHwB_pHFGSWojaUwZidKJSGtuIhVTXjLujAxruqdnaf9SnFwlV1Pwtz0LU-tDdAtuHhlhvPYAV3r0CuT69gZhnkkvtx3z1OvmH56zlx0EmjS35WU41Ii8URXyUTxdzrdz0TuC-ZavhgnneA6u20-t40zudiZjvWOe_1Nx_Oa__IQfDREle3XPmYcpWy3AzGmz1b4Iu4d1EN5gRIaODCp_ThDZKdH39XxHyka3c4SJBGkk8XKvDwND7JNagsvjo4uDftRctRAZnvA0eJHMWIfOBmJeZJxpdMWY0qlwZeLiWCvHqMpMLIUz2lGdxNqKzCB7s1Qx_gumq2FlV4BIndsSnSplTIK2uUol5rSUalnmIk97sN1WemEaHXJ_HcZ90fojWBtFqI0ebHWmj7X4xkdGa23LFQ3-RoXXsZM0z3jWg80uGZHjt0NUZYcTb0PRmUIKmPdguW7xrhSWe1ka__Lt0G6fF1_sn_TDw--vm67CLPPsIBxpXIPp8dPEriO3GeuN0In_AX7Z8zM
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB71IVEupVAKCy0YxKGXVI7jPCz1ArRVKLs9oK60FxTZjq1uu82ifVz66xk7D1haJMQtksdxYvuzv_HYnwE-CG21FNQEQusy4KXlgVKRDmRIo5JFVgu_pju4SPIhPx_FozU4bs_C1PoQ3YKbQ4Yfrx3A3YL0byhX11eI81Qk67Dp43OOEn1jv2IING7uy0txsOFZoyvk9vF0WVdno3sUc5Wx-inn7Al8bz-23mlyc7RcqCN994eO4__-zQ5sN1yUfKw7z1NYM9UzeDRoou27cHxS78Mbz8nUknHljgoiQSVqUk95pGykO-eYSJBJEqf4ejvWxMzkcxienV5-zoPmtoVAR3GUeEeSaWPR30DY8zRiCr0xJlXCbRnbMFTSMipTHQputbJUxaEyPNVI4AyVLNqDjWpamZdAhMpMiX6V1DpG20wmAnMaSpUoM54lPThsa73QjRS5uxFjUrQuCdZG4WujB-870x-1_sZDRvtt0xUNBOeFk7ITNEujtAfvumQEj4uIyMpMl86Goj-FLDDrwYu6ybtSWOaUadzLD33D_b344tN57h9e_bvpW9jKLwf9ov_l4utreMwcWfAnHPdhYzFbmgOkOgv1xvfon73k91E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFH6iIKFeSllKp2wGceAS5DjOYsGlLKNhFaqKxKFSZDu2mJZmEDNz4dfz7CwsLRLiFsnPcWL78_uel88Am0JbLQU1gdC6CHhheaBUpAMZ0qhgkdXCz-menSe9S358FV9NwE5zFqbSh2gn3Bwy_HjtAH5b2CcgV7-vEeapSD7AFE_QTTpG9IM9LiHQuL4uL8Wxhme1rJDbxtNmfe6M_mGYzwmr9zjdGfjVfGu10eTP9niktvX9CxnHd_7MZ_hUM1Hyveo6szBhyjmYPqvX2udh96DahdcfkoEl_dIdFER6StRN5fBIUQt3DjGRII8kTu_1b18TcycX4LJ7-HO_F9R3LQQ6iqPEh5FMG4vRBoKepxFTGIsxqRJui9iGoZKWUZnqUHCrlaUqDpXhqUb6Zqhk0ReYLAel-QpEqMwUGFVJrWO0zWQiMKehVIki41nSga2m0nNdC5G7-zBu8iYgwdrIfW10YKM1va3UN_5ntNy0XF4DcJg7ITtBszRKO7DeJiN03HqILM1g7GwoRlPIAbMOLFYt3pbCMqdL416-5dvt9eLzveOef_j2dtM1mL446OanR-cnS_CROabgjzcuw-TobmxWkOeM1Krvzw_e0_YA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis+of+inherited+bleeding+disorders+in+the+genomic+era&rft.jtitle=British+journal+of+haematology&rft.au=Sivapalaratnam%2C+Suthesh&rft.au=Collins%2C+Janine&rft.au=Gomez%2C+Keith&rft.date=2017-11-01&rft.issn=0007-1048&rft.eissn=1365-2141&rft.volume=179&rft.issue=3&rft.spage=363&rft.epage=376&rft_id=info:doi/10.1111%2Fbjh.14796&rft.externalDBID=10.1111%252Fbjh.14796&rft.externalDocID=BJH14796
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1048&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1048&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1048&client=summon